Anti-retroviral therapy of AIDS and related disorders: General principles and specific development of dideoxynucleosides
- 1 January 1989
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 40 (3) , 329-348
- https://doi.org/10.1016/0163-7258(89)90083-1
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivityBiochemical Pharmacology, 1987
- Structure and conformation of 3′-azido-3′-deoxythymidine (AZT), an inhibitor of the HIV (AIDS) virusCanadian Journal of Chemistry, 1987
- Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityBiochemical Pharmacology, 1987
- WERNICKE'S ENCEPHALOPATHY IN AIDS PATIENT TREATED WITH ZIDOVUDINEThe Lancet, 1987
- Different patterns of inhibition of avian myeloblastosis virus reverse transcriptase activity by 3'-azido-3'-deoxythymidine 5'-triphosphate and its threo isomerAntimicrobial Agents and Chemotherapy, 1987
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivityBiochemical Pharmacology, 1986
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Antiviral, antimetabolic and antineoplastic activities of 2′-or 3′-amino or -azido-substituted deoxyribonucleosidesBiochemical Pharmacology, 1980